FDA Testimony of David Wiseman, PhD - Evidence for Boosters is Weak, Safety Data Is Concerning

Rumble Dr. David Wiseman presents data to the FDA Vaccine Advisory Committee during their September 17, 2021 meeting.

BREAKING: Rumble to Combine with NASDAQ listed CFVI